Next week, researchers from Stanford will publish the results of a study in mice in which intravenous Vitamin C is active against cancer. This new research is based off of a recognition that absorption of Vitamin C by the intestines is limited, and thus intravenous application is needed to get the dosage high enough to see an effect.